Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

2.4K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.4K
Gene Therapy00:59

Gene Therapy

27.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Group Therapy01:26

Group Therapy

450
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
450
Cancer Therapies02:49

Cancer Therapies

10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Behavior Therapy01:22

Behavior Therapy

726
Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
726
Drug Therapy01:28

Drug Therapy

301
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
301

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rates, Timing, and Predictors of Retreatment Across Risk-Cohorts in Retinopathy of Prematurity: Intravitreal Bevacizumab Injection vs Laser.

American journal of ophthalmology·2026
Same author

Genetic Testing in Inherited Retinal Disease: Current Strategies and Future Directions.

Journal of personalized medicine·2026
Same author

Trends in the Initial Treatment for Retinopathy of Prematurity in the United States.

Ophthalmic surgery, lasers & imaging retina·2026
Same author

Bilateral Opposing Lens Dislocation and Retinal Detachment in LTBP2-Associated Weill-Marchesani Syndrome: Surgical Sequencing and Multidisciplinary Pediatric Management.

Retinal cases & brief reports·2026
Same author

Minimizing Risk in Scleral Buckle Surgery: A Novel Approach to Belt Loop Creation Using a Guarded Diamond Blade.

Retinal cases & brief reports·2026
Same author

Multi-grader validation of the telemedicine retinopathy of prematurity severity score.

Scientific reports·2026

Related Experiment Video

Updated: Feb 6, 2026

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
10:24

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

10.8K

Stargardt macular dystrophy and evolving therapies.

Rehan M Hussain1, Thomas A Ciulla2, Audina M Berrocal1

  • 1a Department of Ophthalmology, Bascom Palmer Eye Institute , University of Miami Miller School of Medicine , Miami , FL , USA.

Expert Opinion on Biological Therapy
|August 22, 2018
PubMed
Summary

Investigational treatments for Stargardt macular dystrophy (STGD1) include gene therapy, stem cell therapy, visual cycle modulators, and complement inhibitors. Further human trials are needed to confirm efficacy and safety for this hereditary retinal degeneration.

Keywords:
ABCA4C20-D3-vitamin ASAR422459Stargardt macular dystrophycomplement inhibitiongene therapystem cell therapyvisual cycle

More Related Videos

A Simple and Low-cost Assay for Measuring Ambulation in Mouse Models of Muscular Dystrophy
05:54

A Simple and Low-cost Assay for Measuring Ambulation in Mouse Models of Muscular Dystrophy

Published on: December 29, 2017

10.5K
Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
10:30

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy

Published on: May 24, 2016

19.3K

Related Experiment Videos

Last Updated: Feb 6, 2026

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
10:24

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

10.8K
A Simple and Low-cost Assay for Measuring Ambulation in Mouse Models of Muscular Dystrophy
05:54

A Simple and Low-cost Assay for Measuring Ambulation in Mouse Models of Muscular Dystrophy

Published on: December 29, 2017

10.5K
Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
10:30

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy

Published on: May 24, 2016

19.3K

Area of Science:

  • Ophthalmology
  • Genetics
  • Regenerative Medicine

Background:

  • Stargardt macular dystrophy (STGD1) is an inherited retinal disease with limited treatment options.
  • Accumulation of toxic bisretinoids and lipofuscin in the retina and retinal pigment epithelium (RPE) is a hallmark of STGD1.

Purpose of the Study:

  • To review current and emerging therapeutic strategies for STGD1.
  • To discuss the potential of gene therapy, stem cell therapy, and pharmacotherapy.

Main Methods:

  • Review of investigational therapies including ALK-001, isotretinoin, VM200, emixustat, A1120, and avacincaptad pegol.
  • Discussion of stem cell transplantation and ABCA4 gene therapy approaches.
  • Analysis of clinical trial data and animal model outcomes for STGD1 treatments.

Main Results:

  • Several pharmacotherapies aim to reduce toxic retinal deposits, with some showing promise in animal models but lacking human efficacy data.
  • Visual cycle modulators (VCMs) like fenretinide and emixustat have shown limited success in related conditions.
  • Stem cell therapy and gene therapy targeting the ABCA4 gene present biologically plausible mechanisms, with early-phase trials ongoing.

Conclusions:

  • Stem cell transplantation, ABCA4 gene therapy, VCMs, and complement inhibitors offer potential therapeutic avenues for STGD1.
  • Further clinical trials are essential to evaluate the safety and efficacy of these treatments in humans.